Department of Surgery, University of California San Diego, San Diego, California.
Department of Surgery, University of California San Diego, San Diego, California.
J Surg Res. 2014 Aug;190(2):517-21. doi: 10.1016/j.jss.2014.02.043. Epub 2014 Feb 28.
Acute acalculous cholecystitis is often managed with cholecystectomy or cholecystostomy, but data guiding surgical practice are lacking.
Longitudinal analysis of the California Office of Statewide Health Planning and Development Patient Discharge Data was performed from 1995-2009. Patients with acute acalculous cholecystitis were identified by International Classification of Diseases 9 code. Cox proportional hazard analysis found predictors of time to death, adjusting for patient demographics, sepsis, shock, frailty, Charlson comorbidity index, length of stay, insurance status, teaching hospital status, and year.
Of 43,341 patients, 63.5% received a cholecystectomy, 2.8% received a cholecystostomy, and 1.2% received both. Overall, 30.4% of patients died, with higher mortality among patients with cholecystostomy (61.7%) or no procedure (42.0%) than cholecystectomy (23.0%). In patients with severe sepsis and shock, there was no difference in survival of patients with cholecystostomy versus no intervention (hazard ratio [HR] 1.13, P = 0.256), although patients with cholecystectomy (with or without prior cholecystostomy) had improved survival (HR 0.29, P < 0.001; HR 0.56, P < 0.001). Results were similar among patients on the ventilator >96 h.
Although cholecystostomy offered no survival benefit for patients with severe sepsis and shock, cholecystectomy offered improved survival compared with patients without surgical management. Cholecystostomy may not benefit the sickest patients in whom cholecystectomy may never be considered.
急性非结石性胆囊炎常采用胆囊切除术或胆囊造口术治疗,但缺乏指导手术实践的数据。
对 1995 年至 2009 年加州全州卫生规划和发展患者出院数据进行了纵向分析。通过国际疾病分类第 9 代码识别出急性非结石性胆囊炎患者。使用 Cox 比例风险分析,根据患者人口统计学、败血症、休克、虚弱、Charlson 合并症指数、住院时间、保险状况、教学医院状况和年份,调整了死亡时间的预测因素。
在 43341 名患者中,63.5%接受了胆囊切除术,2.8%接受了胆囊造口术,1.2%同时接受了两种手术。总体而言,30.4%的患者死亡,胆囊造口术(61.7%)或无手术(42.0%)的患者死亡率高于胆囊切除术(23.0%)。在严重败血症和休克患者中,胆囊造口术与无干预措施相比,患者的存活率无差异(危险比[HR]1.13,P=0.256),尽管接受胆囊切除术(有或无先前的胆囊造口术)的患者存活率有所提高(HR 0.29,P<0.001;HR 0.56,P<0.001)。在呼吸机使用时间超过 96 小时的患者中,结果相似。
尽管胆囊造口术对严重败血症和休克患者没有生存获益,但与未接受手术治疗的患者相比,胆囊切除术提高了生存率。胆囊造口术可能对病情最严重的患者无益,因为可能从未考虑过对这些患者进行胆囊切除术。